Artificial Gravity Attenuates the Transcriptomic Response to Spaceflight in the Optic Nerve and Retina
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212041 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Isaac Kremsky und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Sciences, Division of Biomedical Engineering Sciences (BMES), Loma Linda University School of Medicine, Loma Linda, CA 92350, USA. Hauptthemen laut MEDLINE: Space Flight, Retina, Gravity, Altered, Transcriptome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Japan Aerospace Exploration Agency, NIH HHS.
Abstract (Originalsprache)
The development of eye pathology is a serious concern for astronauts who spend time in deep space. Microgravity is a major component of the spaceflight environment which could have adverse effects on ocular health. The use of centrifugation to exert forces that partially or fully mimic Earth-level gravity in space is a possible countermeasure to mitigate the effects of microgravity on the eye. Therefore, we subjected mice on the International Space Station (ISS) to microgravity (0 G) or artificial gravity by centrifugation at 0.33 G, 0.67 G, and 1 G, and then performed RNA sequencing (RNA-seq) on optic nerve and retinal tissue after returning them to Earth alive. We find that the microgravity environment induces transcriptomic changes in the optic nerve and retina consistent with an increased oxidative stress load, inflammation, apoptosis, and lipid metabolic stress. We also find that adding artificial gravity on board the ISS attenuates the transcriptomic response to microgravity in a dose-dependent manner. Such attenuation may effectively protect from and mitigate spaceflight-induced detrimental effects on ocular tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Sciences, Division of Biomedical Engineering Sciences (BMES), Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
- Center for Genomics, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
- Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC 27101, USA.
- Department of Neurobiology, Physiology & Behavior, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA.
- Laboratory Animal Resource Center in Transborder Medical Research Center, Department of Anatomy and Embryology, Institute of Medicine, University of Tsukuba, Tsukuba 305-8575, Ibaraki, Japan.
- Center for Sleep and Circadian Biology, Department of Neurobiology, Northwestern University, Evanston, IL 60208, USA.
ORCID-Profile: Seta Stanbouly, Satoru Takahashi, Martha Hotz Vitaterna, Xiaowen Mao
Förderung
- NIGMS NIH HHS
- Japan Aerospace Exploration Agency
- NIH HHS
- NASA
- NIH
Zitieren
APA
Kremsky, I., Pergerson, R., Justinen, S., Stanbouly, S., Willey, J., Fuller, C. A., Takahashi, S., Vitaterna, M. H., Bouxsein, M., & Mao, X. (2024). Artificial Gravity Attenuates the Transcriptomic Response to Spaceflight in the Optic Nerve and Retina. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212041
Vancouver
Kremsky I, Pergerson R, Justinen S, Stanbouly S, Willey J, Fuller CA, et al. Artificial Gravity Attenuates the Transcriptomic Response to Spaceflight in the Optic Nerve and Retina. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212041
BibTeX
@article{Kremsky2024,
author = {Kremsky, Isaac and Pergerson, Reyna and Justinen, Stephen and Stanbouly, Seta and Willey, Jeffrey and Fuller, Charles A and Takahashi, Satoru and Vitaterna, Martha Hotz and Bouxsein, Mary and Mao, Xiaowen},
title = {Artificial Gravity Attenuates the Transcriptomic Response to Spaceflight in the Optic Nerve and Retina},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212041}
}
EUVIMED